By loosening standards, the FDA isn’t doing rare-disease patients any favors (Los Angeles Times, 10/19/25)

A Court Decision on Lab-Developed Tests Sets a Dangerous Precedent (STAT News, 5/05/25)

The Sudden Dismissal of Public Records Staff at Health Agencies Threatens Government Accountability (The Conversation, 4/16/25)

Gutting FDA Won't Make America Healthy (MedPageToday, 3/04/25)

The Fight to Reclaim Technical Expertise Amid the Fall of Chevron Deference (AI Now, 8/01/24)

To get a fair deal on Wegovy, buying Novo Nordisk might not be Medicare's worst option (STAT News, 7/23/24)

Victory Over Big Pharma Will Take More Than the IRA (MedPage Today, 4/04/24)

Reasonable Pricing Clauses: A First Step Toward Ensuring Taxpayers a Fair Return on their Public R&D Investment (Harvard Law, 9/28/23)

Do Advocacy Groups always put patients first? (Medpage Today, 8/29/23)

Should FDA Grant Accelerated Approval to Duchenne Muscular Dystrophy Gene Therapy? (MedPage Today, 5/18/23)

Want to make drugs, including insulin, affordable? End patent abuse. | GUEST COMMENTARY (The Baltimore Sun, 3/03/23)